Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria

NCT07559370 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

1116

Enrollment

OTHER

Sponsor class

Conditions

Malaria (Plasmodium Falciparum)

Interventions

DRUG: Artemether/lumefantrine tablets
DRUG: Artemether/Lumefantrine + Imatinib Mesylate

Sponsor

Victoria Biomedical Research Institute